3,056
Views
132
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

PDGF and PDGF receptors in glioma

, , , , , & show all
Pages 99-112 | Received 24 Jan 2012, Accepted 06 Feb 2012, Published online: 17 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Candice D. Carpenter, Iyad Alnahhas, Javier Gonzalez, Pierre Giglio & Vinay K. Puduvalli. (2019) Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target. Expert Review of Neurotherapeutics 19:7, pages 663-677.
Read now
Matthew Harris, Fredrik Svensson, Liliya Kopanitsa, Graham Ladds & David Bailey. (2018) Emerging patents in the therapeutic areas of glioma and glioblastoma. Expert Opinion on Therapeutic Patents 28:7, pages 573-590.
Read now
Yinghong Zhou, Mengchao Shi, Julian R. Jones, Zetao Chen, Jiang Chang, Chengtie Wu & Yin Xiao. (2017) Strategies to direct vascularisation using mesoporous bioactive glass-based biomaterials for bone regeneration. International Materials Reviews 62:7, pages 392-414.
Read now
Arne Andersson & Joey Lau Börjesson. (2016) Scholarly publishing threatened?. Upsala Journal of Medical Sciences 121:4, pages 205-206.
Read now
Bengt Westermark. (2014) Platelet-derived growth factor in glioblastoma—driver or biomarker?. Upsala Journal of Medical Sciences 119:4, pages 298-305.
Read now
Arne Andersson. (2014) Further improvements of our journal performance figures. Upsala Journal of Medical Sciences 119:4, pages 295-297.
Read now
Monika Ehnman & Arne Östman. (2014) Therapeutic targeting of platelet-derived growth factor receptors in solid tumors. Expert Opinion on Investigational Drugs 23:2, pages 211-226.
Read now
Zabi Wardak & Kevin S Choe. (2013) Molecular pathways and potential therapeutic targets in glioblastoma multiforme. Expert Review of Anticancer Therapy 13:11, pages 1307-1318.
Read now
E. Hervouet, O. Staehlin, D. Pouliquen, E. Debien, P-F. Cartron, J. Menanteau, F.M. Vallette & C. Olivier. (2013) Antioxidants Delay Clinical Signs and Systemic Effects of ENU Induced Brain Tumors in Rats. Nutrition and Cancer 65:5, pages 686-694.
Read now
Bengt Westermark. (2012) Glioblastoma—a moving target. Upsala Journal of Medical Sciences 117:2, pages 251-256.
Read now

Articles from other publishers (122)

Brian Effer, Isabela Perez, Daniel Ulloa, Carolyn Mayer, Francisca Muñoz, Diego Bustos, Claudio Rojas, Carlos Manterola, Luis Vergara-Gómez, Camila Dappolonnio, Helga Weber & Pamela Leal. (2023) Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging. Biomedicines 11:7, pages 2086.
Crossref
Hiba K Omairi, Cameron J Grisdale, Mathieu Meode, Alexandra K Bohm, Sophie Black, Nancy J Adam, Cassidy P Chapman, Tatiana Maroilley, John J Kelly, Maja Tarailo-Graovac, Steven J M Jones, Michael D Blough & John Gregory Cairncross. (2023) Mitogen-induced defective mitosis transforms neural progenitor cells. Neuro-Oncology.
Crossref
Yin-Hao Shi, Qiong-Cong Xu, Ying-Qin Zhu, Zhi-De Liu, Guang-Yin Zhao, Qi Liu, Xi-Yu Wang, Jie-Qin Wang, Xiang Xu, Qiao Su, Jia-Ming Lai, Chen-Song Huang & Xiao-Yu Yin. (2023) Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. Molecular Therapy 31:2, pages 503-516.
Crossref
Daniela Meco, Giorgio Attinà, Stefano Mastrangelo, Pierluigi Navarra & Antonio Ruggiero. (2023) Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers. International Journal of Molecular Sciences 24:2, pages 1334.
Crossref
Faris Hermawan, Jumina, Harno Dwi Pranowo, Eti Nurwening Sholikhah & Muthia Rahayu Iresha. (2022) Molecular Docking Approach For Design and Synthesis of Thioxanthone Derivatives as Anticancer Agents. ChemistrySelect 7:46.
Crossref
José Marcos Jiménez-Morales, Yanet Elisa Hernández-Cuenca, Ander Reyes-Abrahantes, Henry Ruiz-García, Francisco Barajas-Olmos, Humberto García-Ortiz, Lorena Orozco, Alfredo Quiñones-Hinojosa, Jesús Reyes-González & María del Carmen Abrahantes-Pérez. (2022) MicroRNA delivery systems in glioma therapy and perspectives: A systematic review. Journal of Controlled Release 349, pages 712-730.
Crossref
Iyman Amin & Prashant Saxena. (2022) Glioblastoma a Malignant Form of Tumor: a Review on Its Cellular Target, Route, and Its Treatment. Current Tissue Microenvironment Reports 3:3, pages 51-60.
Crossref
Deguan Lv, Ryan C. Gimple, Cuiqing Zhong, Qiulian Wu, Kailin Yang, Briana C. Prager, Bhaskar Godugu, Zhixin Qiu, Linjie Zhao, Guoxin Zhang, Deobrat Dixit, Derrick Lee, Jia Z. Shen, Xiqing Li, Qi Xie, Xiuxing Wang, Sameer Agnihotri & Jeremy N. Rich. (2022) PDGF signaling inhibits mitophagy in glioblastoma stem cells through N-methyladenosine. Developmental Cell.
Crossref
Hui Liu, Weimin Qiu, Tianyu Sun, Lei Wang, Chenxi Du, Yanyu Hu, Wenyuan Liu, Feng Feng, Yao Chen & Haopeng Sun. (2022) Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds. Acta Pharmaceutica Sinica B 12:4, pages 1781-1804.
Crossref
Philip Gerlee, Philipp M. Altrock, Adam Malik, Cecilia Krona & Sven Nelander. (2022) Autocrine signaling can explain the emergence of Allee effects in cancer cell populations. PLOS Computational Biology 18:3, pages e1009844.
Crossref
Qu-Jing Gai, Zhen Fu, Jiang He, Min Mao, Xiao-Xue Yao, Yan Qin, Xi Lan, Lin Zhang, Jing-Ya Miao, Yan-Xia Wang, Jiang Zhu, Fei-Cheng Yang, Hui-Min Lu, Ze-Xuan Yan, Fang-Lin Chen, Yu Shi, Yi-Fang Ping, You-Hong Cui, Xia Zhang, Xindong Liu, Xiao-Hong Yao, Sheng-Qing Lv, Xiu-Wu Bian & Yan Wang. (2022) EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma. Signal Transduction and Targeted Therapy 7:1.
Crossref
Gayathri Chandrasekar, VinayScheel Bansal, Manas Panigrahi & SatishS Kitambi. (2022) An overview of targets and therapies for glioblastoma multiforme. Journal of Cancer Research and Therapeutics 18:3, pages 591.
Crossref
Joseline Haizel-Cobbina, Rut Thakkar, Kelsey Richard, Liping Du, Adrian Levine, Julie Bennett, Cynthia Hawkins, Uri Tabori & Michael C Dewan. (2022) Clinical and molecular features of disseminated pediatric low-grade glioma and glioneuronal tumors: a systematic review and survival analysis. Neuro-Oncology Advances 4:1.
Crossref
Nayuta Higa, Toshiaki Akahane, Seiya Yokoyama, Hajime Yonezawa, Hiroyuki Uchida, Tomoko Takajo, Ryosuke Otsuji, Taiji Hamada, Kei Matsuo, Mari Kirishima, Nobuhiro Hata, Ryosuke Hanaya, Akihide Tanimoto & Koji Yoshimoto. (2022) Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma . Neuro-Oncology Advances 4:1.
Crossref
Sajita Shah & Gina M. Sizemore. 2022. Stromal Signaling in Cancer. Stromal Signaling in Cancer 93 140 .
Shengnan Yu, Shiyou Wei, Milan Savani, Xiang Lin, Kuang Du, Ilgen Mender, Silvia Siteni, Themistoklis Vasilopoulos, Zachary J. Reitman, Yin Ku, Di Wu, Hao Liu, Meng Tian, Yaohui Chen, Marilyne Labrie, Casey M. Charbonneau, Eric Sugarman, Michelle Bowie, Seethalakshmi Hariharan, Matthew Waitkus, Wen Jiang, Roger E. McLendon, Edward Pan, Mustafa Khasraw, Kyle M. Walsh, Yiling Lu, Meenhard Herlyn, Gordon Mills, Utz Herbig, Zhi Wei, Stephen T. Keir, Keith Flaherty, Lunxu Liu, Kongming Wu, Jerry W. Shay, Kalil Abdullah, Gao Zhang & David M. Ashley. (2021) A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas. Clinical Cancer Research 27:24, pages 6800-6814.
Crossref
Gong Peng, Yin Wang, Pengfei Ge, Christopher Bailey, Peng Zhang, Di Zhang, Zhaoli Meng, Chong Qi, Qian Chen, Jingtao Chen, Junqi Niu, Pan Zheng, Yang Liu & Yan Liu. (2021) The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Purva P. Nagarajan, Muhibullah S. Tora, Stewart G. Neill, Thais Federici, Pavlos Texakalidis, Anthony Donsante, Peter Canoll, Kecheng Lei & Nicholas M. Boulis. (2021) Lentiviral-Induced Spinal Cord Gliomas in Rat Model. International Journal of Molecular Sciences 22:23, pages 12943.
Crossref
Hasan Turkez, Ozlem Ozdemir Tozlu, Mehmet Enes Arslan & Adil Mardinoglu. (2021) Safety and Efficacy Assessments to Take Antioxidants in Glioblastoma Therapy: From In Vitro Experiences to Animal and Clinical Studies. Neurochemistry International 150, pages 105168.
Crossref
Feng Yan, Jianfeng Zhuang, Qian Yu, Zhangqi Dou, Xuefeng Jiang, Shuyu Tan, Yifeng Han, Xinyan Wu, Yi Zang, Cong Li, Jia Li, Huaijun Chen, Libin Hu, Xin Li & Gao Chen. (2021) Strategy of De Novo Design toward First-In-Class Imaging Agents for Simultaneously Differentiating Glioma Boundary and Grades . ACS Sensors 6:9, pages 3330-3339.
Crossref
Andrea Comba, Syed M. Faisal, Maria Luisa Varela, Todd Hollon, Wajd N. Al-Holou, Yoshie Umemura, Felipe J. Nunez, Sebastien Motsch, Maria G. Castro & Pedro R. Lowenstein. (2021) Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications. Frontiers in Oncology 11.
Crossref
Julie Bolcaen, Shankari Nair, Cathryn Driver, Tebatso Boshomane, Thomas Ebenhan & Charlot Vandevoorde. (2021) Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals 14:7, pages 626.
Crossref
Kaushik Banerjee, Felipe J. Núñez, Santiago Haase, Brandon L. McClellan, Syed M. Faisal, Stephen V. Carney, Jin Yu, Mahmoud S. Alghamri, Antonela S. Asad, Alejandro J. Nicola Candia, Maria Luisa Varela, Marianela Candolfi, Pedro R. Lowenstein & Maria G. Castro. (2021) Current Approaches for Glioma Gene Therapy and Virotherapy. Frontiers in Molecular Neuroscience 14.
Crossref
Jelena Medved, William M. Wood, Michael D. Heyst, Amin Sherafat, Ju‐Young Song, Sagune Sakya, Dennis L. Wright & Akiko Nishiyama. (2020) Novel guanidine compounds inhibit platelet‐derived growth factor receptor alpha transcription and oligodendrocyte precursor cell proliferation. Glia 69:3, pages 792-811.
Crossref
Hong-My Nguyen, Kirsten Guz-Montgomery, Devin B. Lowe & Dipongkor Saha. (2021) Pathogenetic Features and Current Management of Glioblastoma. Cancers 13:4, pages 856.
Crossref
Motomichi Fujita, Manabu Sasada, Takuya Iyoda, Reo Nagai, Chikako Kudo, Tetsuya Yamamoto, Satoshi Osada, Hiroaki Kodama & Fumio Fukai. (2021) Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation. Biochemical and Biophysical Research Communications 536, pages 14-19.
Crossref
Motomichi Fujita, Manabu Sasada, Takuya Iyoda & Fumio Fukai. (2020) Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide. Molecules 25:14, pages 3239.
Crossref
Anahita Fathi Kazerooni, Spyridon Bakas, Hamidreza Saligheh Rad & Christos Davatzikos. (2019) Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review. Journal of Magnetic Resonance Imaging 52:1, pages 54-69.
Crossref
Kayoung Shin, Hyemi Shin, Hee Jin Cho, Hyunju Kang, Jin-Ku Lee, Yun Jee Seo, Yong Jae Shin, Donggeon Kim, Harim Koo, Doo-Sik Kong, Ho Jun Seol, Jung-Il Lee, Hye Won Lee & Do-Hyun Nam. (2020) Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening. Cancers 12:3, pages 549.
Crossref
Jill A. Gallaher, Susan C. Massey, Andrea Hawkins-Daarud, Sonal S. Noticewala, Russell C. Rockne, Sandra K. Johnston, Luis Gonzalez-Cuyar, Joseph Juliano, Orlando Gil, Kristin R. Swanson, Peter Canoll & Alexander R. A. Anderson. (2020) From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response. PLOS Computational Biology 16:2, pages e1007672.
Crossref
Melinda N. Tea, Santosh I. Poonnoose & Stuart M. Pitson. (2020) Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma. Cancers 12:1, pages 111.
Crossref
Athina-Maria Aloizou, Georgia Pateraki, Vasileios Siokas, Alexios-Fotios A. Mentis, Ioannis Liampas, George Lazopoulos, Leda Kovatsi, Panayiotis D. Mitsias, Dimitrios P. Bogdanos, Konstantinos Paterakis & Efthimios Dardiotis. (2020) The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention?. Toxicology Reports 7, pages 1514-1530.
Crossref
H. Taghizadeh, L. Müllauer, J. Furtner, J. A. Hainfellner, C. Marosi, M. Preusser & G. W. Prager. (2019) Applied Precision Cancer Medicine in Neuro-Oncology. Scientific Reports 9:1.
Crossref
Uri Rozovski, David M. Harris, Ping Li, Zhiming Liu, Preetesh Jain, Alessandra Ferrajoli, Jan A. Burger, Prithviraj Bose, Phillip A. Thompson, Nitin Jain, William G. Wierda, Orit Uziel, Michael J. Keating & Zeev Estrov. (2019) STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage. The Journal of Immunology 203:11, pages 3078-3085.
Crossref
Jui-Chieh Chen, I-Neng Lee, Cheng Huang, Yu-Ping Wu, Chiu-Yen Chung, Ming-Hsueh Lee, Martin Hsiu-Chu Lin & Jen-Tsung Yang. (2019) Valproic acid-induced amphiregulin secretion confers resistance to temozolomide treatment in human glioma cells. BMC Cancer 19:1.
Crossref
Sara Pedron, Gabrielle L. Wolter, Jee-Wei E. Chen, Sarah E. Laken, Jann N. Sarkaria & Brendan A.C. Harley. (2019) Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens. Biomaterials 219, pages 119371.
Crossref
Laura M. Prolo, Amy Li, Scott F. Owen, Jonathon J. Parker, Kara Foshay, Ryan T. Nitta, David W. Morgens, Sara Bolin, Christy M. Wilson, Johana C. M. Vega L, Emily J. Luo, Gigi Nwagbo, Allen Waziri, Gordon Li, Richard J. Reimer, Michael C. Bassik & Gerald A. Grant. (2019) Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion. Scientific Reports 9:1.
Crossref
Olivia G. Taylor, Joshua S. Brzozowski & Kathryn A. Skelding. (2019) Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets. Frontiers in Oncology 9.
Crossref
Youyi Zhang, Jeffrey S. Morris, Shivali Narang Aerry, Arvind U. K. Rao & Veerabhadran Baladandayuthapani. (2019) Radio-iBAG: Radiomics-based integrative Bayesian analysis of multiplatform genomic data. The Annals of Applied Statistics 13:3.
Crossref
Sanghwa Kim, Jae Yeon Choi, Hyun Jeong Seok, Myung-Jin Park, Hee Yong Chung & In Hwa Bae. (2019) miR-340-5p Suppresses Aggressiveness in Glioblastoma Multiforme by Targeting Bcl-w and Sox2. Molecular Therapy - Nucleic Acids 17, pages 245-255.
Crossref
E. F. Valiakhmetova, L. A. Yasko, L. I. Papusha, A. E. Druy & A. I. Karachunsky. (2019) Promises of targeted therapy for low grade gliomas in children. Advances in molecular oncology 6:2, pages 28-41.
Crossref
Motomichi Fujita, Tetsuya Yamamoto, Takuya Iyoda, Tatsuya Fujisawa, Reo Nagai, Chikako Kudo, Manabu Sasada, Hiroaki Kodama & Fumio Fukai. (2019) Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells. International Journal of Molecular Sciences 20:13, pages 3183.
Crossref
Margaux Colin, Cédric Delporte, Rekin’s Janky, Anne-Sophie Lechon, Gwendoline Renard, Pierre Van Antwerpen, William A. Maltese & Véronique Mathieu. (2019) Dysregulation of Macropinocytosis Processes in Glioblastomas May Be Exploited to Increase Intracellular Anti-Cancer Drug Levels: The Example of Temozolomide. Cancers 11:3, pages 411.
Crossref
Pohchoo Seow, Jeannie Hsiu Ding Wong, Azlina Ahmad-Annuar, Abhishek Mahajan, Nor Aniza Abdullah & Norlisah Ramli. (2018) Quantitative magnetic resonance imaging and radiogenomic biomarkers for glioma characterisation: a systematic review. The British Journal of Radiology 91:1092, pages 20170930.
Crossref
Chiara Bardella, Abeer R. Al-Shammari, Luana Soares, Ian Tomlinson, Eric O'Neill & Francis G. Szele. (2018) The role of inflammation in subventricular zone cancer. Progress in Neurobiology 170, pages 37-52.
Crossref
Puja Sharma & Waldemar Debinski. (2018) Receptor-Targeted Glial Brain Tumor Therapies. International Journal of Molecular Sciences 19:11, pages 3326.
Crossref
Devin B. Mair, Heather M. Ames & Rong Li. (2018) Mechanisms of invasion and motility of high-grade gliomas in the brain. Molecular Biology of the Cell 29:21, pages 2509-2515.
Crossref
Jacob S Young, Michael D Prados & Nicholas Butowski. (2018) Using genomics to guide treatment for glioblastoma. Pharmacogenomics 19:15, pages 1217-1229.
Crossref
Gulten Tuncel & Rasime Kalkan. (2018) Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme. Medical Oncology 35:9.
Crossref
Meghan R. Pinezich, Lauren N. Russell, Nicholas P. Murphy & Kyle J. Lampe. (2018) Encapsulated oligodendrocyte precursor cell fate is dependent on PDGF-AA release kinetics in a 3D microparticle-hydrogel drug delivery system. Journal of Biomedical Materials Research Part A 106:9, pages 2402-2411.
Crossref
Natalia Papadopoulos & Johan Lennartsson. (2018) The PDGF/PDGFR pathway as a drug target. Molecular Aspects of Medicine 62, pages 75-88.
Crossref
Rebecca A. Harrison & John F. de Groot. (2018) Treatment of Glioblastoma in the Elderly. Drugs & Aging 35:8, pages 707-718.
Crossref
Qungen Xiao, Minghai Dong, Fangling Cheng, Feng Mao, Weifeng Zong, Kang Wu, Heping Wang, Ruifan Xie, Baofeng Wang, Ting Lei & Dongsheng Guo. (2018) LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling. International Journal of Oncology.
Crossref
Sara Jansson, Kristina Aaltonen, Pär-Ola Bendahl, Anna-Karin Falck, Maria Karlsson, Kristian Pietras & Lisa Rydén. (2018) The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence. Breast Cancer Research and Treatment 169:2, pages 231-241.
Crossref
Claudia Quezada, Ángelo Torres, Ignacio Niechi, Daniel Uribe, Susana Contreras-Duarte, Fernando Toledo, Rody San Martín, Jaime Gutiérrez & Luis Sobrevia. (2018) Role of extracellular vesicles in glioma progression. Molecular Aspects of Medicine 60, pages 38-51.
Crossref
Wioletta K. Glowacka, Harshika Jain, Makiko Okura, Abulizi Maimaitiming, Yasin Mamatjan, Romina Nejad, Hamza Farooq, Michael D. Taylor, Kenneth Aldape & Paul Kongkham. (2018) 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma. Acta Neuropathologica 135:4, pages 617-634.
Crossref
Ali Kadivar, Mohamed Ibrahim Noordin, Arya Aditya, Behnam Kamalidehghan, Ehsan Davoudi, Reihaneh Sedghi & Hamid Akbari Javar. (2018) Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression. International Journal of Molecular Medicine.
Crossref
Gilbert J Rahme, Bryan W Luikart, Chao Cheng & Mark A Israel. (2018) A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma. Neuro-Oncology 20:3, pages 332-342.
Crossref
Andrew Octavian SasmitaYing Pei WongAnna Pick Kiong Ling. (2018) Biomarkers and therapeutic advances in glioblastoma multiforme. Asia-Pacific Journal of Clinical Oncology 14:1, pages 40-51.
Crossref
Juhi Singh, Kedarlal Sharma & Prakash P. Pillai. (2017) PDGFR inhibition mediated intracellular signalling in C6 glioma growth and migration: role of ERK and ROCK pathway. Cytotechnology 70:1, pages 465-477.
Crossref
Jan Korbecki, Izabela Gutowska, Ireneusz Kojder, Dariusz Jeżewski, Marta Goschorska, Agnieszka Łukomska, Anna Lubkowska, Dariusz Chlubek & Irena Baranowska-Bosiacka. (2018) New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection. Oncotarget 9:6, pages 7219-7270.
Crossref
Alexander D. Barrow, Melissa A. Edeling, Vladimir Trifonov, Jingqin Luo, Piyush Goyal, Benjamin Bohl, Jennifer K. Bando, Albert H. Kim, John Walker, Mary Andahazy, Mattia Bugatti, Laura Melocchi, William Vermi, Daved H. Fremont, Sarah Cox, Marina Cella, Christian Schmedt & Marco Colonna. (2018) Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. Cell 172:3, pages 534-548.e19.
Crossref
Flávia Sousa, Rui P. Moura, Elias Moreira, Cláudia Martins & Bruno Sarmento. 2018. Therapeutic Proteins and Peptides. Therapeutic Proteins and Peptides 61 80 .
Behrooz Torabi Moghadam, Neda Zamani, Jan Komorowski & Manfred Grabherr. (2017) PiiL: visualization of DNA methylation and gene expression data in gene pathways. BMC Genomics 18:1.
Crossref
Isabella Gomes Cantanhede & João Ricardo Mendes de Oliveira. (2017) PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database. Scientific Reports 7:1.
Crossref
Joshua R D Pearson & Tarik Regad. (2017) Targeting cellular pathways in glioblastoma multiforme. Signal Transduction and Targeted Therapy 2:1.
Crossref
Weikun Xiao, Alireza Sohrabi & Stephanie K Seidlits. (2017) Integrating the glioblastoma microenvironment into engineered experimental models. Future Science OA 3:3, pages FSO189.
Crossref
Ji-Dong Hong, Xia Wang, Yu-Ping Peng, Jiang-Hua Peng, Jun Wang, Ye-Ping Dong, Dan He, Zhen-Zi Peng, Qing-Song Tu, Liang-Fang Sheng, Mei-Zuo Zhong & Chao-Jun Duan. (2017) Silencing platelet-derived growth factor receptor-β enhances the radiosensitivity of C6 glioma cells in vitro and in vivo. Oncology Letters 14:1, pages 329-336.
Crossref
Evangelos Pavlakis, Anton B. Tonchev, Ara Kaprelyan, Yavor Enchev & Anastassia Stoykova. (2017) Interaction between transcription factors PAX6/PAX6-5a and specific members of miR-183-96-182 cluster, may contribute to glioma progression in glioblastoma cell lines. Oncology Reports 37:3, pages 1579-1592.
Crossref
Christoph Gerhardt, Tristan Leu, Johanna Maria Lier & Ulrich Rüther. (2016) The cilia-regulated proteasome and its role in the development of ciliopathies and cancer. Cilia 5:1.
Crossref
James A. McCubrey, Dariusz Rakus, Agnieszka Gizak, Linda S. Steelman, Steve L. Abrams, Kvin Lertpiriyapong, Timothy L. Fitzgerald, Li V. Yang, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Ferdinando Nicoletti, Aurora Scalisi, Francesco Torino, Concettina Fenga, Luca M. Neri, Sandra Marmiroli, Lucio Cocco & Alberto M. Martelli. (2016) Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:12, pages 2942-2976.
Crossref
Yin Xu, Kaiqiang Wang & Qin Yu. (2016) FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases. Oncotarget 7:43, pages 70080-70091.
Crossref
Tracy T. Batchelor, Elizabeth R. Gerstner, Xiaobu Ye, Serena Desideri, Daniel G. Duda, David Peereboom, Glenn J. Lesser, Sajeel Chowdhary, Patrick Y. Wen, Stuart Grossman & Jeffrey G. Supko. (2016) Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma. Neuro-Oncology, pages now185.
Crossref
Vinay Kumar Sharma, Anand Singh, Sandeep Kumar Srivastava, Vignesh Kumar, Nilesh Laxman Gardi, Aasma Nalwa, Amit Kumar Dinda, Parthaprasad Chattopadhyay & Savita Yadav. (2016) Increased expression of platelet-derived growth factor associated protein-1 is associated with PDGF-B mediated glioma progression. The International Journal of Biochemistry & Cell Biology 78, pages 194-205.
Crossref
Guiyan Xu & Jian Yi Li. (2016) Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma. Tumor Biology 37:8, pages 10577-10586.
Crossref
ROBERTO GAMBARI, ELEONORA BROGNARA, DEMETRIOS A. SPANDIDOS & ENRICA FABBRI. (2016) Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review). International Journal of Oncology 49:1, pages 5-32.
Crossref
Zammam Areeb, Stanley S. Stylli, Thomas M. B. Ware, Nicole C. Harris, Lipi Shukla, Ramin Shayan, Lucia Paradiso, Bo Li, Andrew P. Morokoff, Andrew H. Kaye & Rodney B. Luwor. (2016) Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib. Medical Oncology 33:5.
Crossref
Hye Min Kim, Yu Kyung Lee & Ja Seung Koo. (2016) Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor. Disease Markers 2016, pages 1-10.
Crossref
Zhenqiang He, Richard Alan MitteerJrJr, Yonggao Mou & Yi Fan. 2016. Glioblastoma. Glioblastoma 55 72 .
Q.N. Tran. 2016. Emerging Trends in Applications and Infrastructures for Computational Biology, Bioinformatics, and Systems Biology. Emerging Trends in Applications and Infrastructures for Computational Biology, Bioinformatics, and Systems Biology 107 120 .
Jenny L. Pokorny, Gaspar J. Kitange & Daniel J. Ma. 2016. Resistance to Targeted Therapies Against Adult Brain Cancers. Resistance to Targeted Therapies Against Adult Brain Cancers 145 174 .
Monica Mangoni, Mariangela Sottili, Chiara Gerini & Lorenzo Livi. 2016. Radiobiology of Glioblastoma. Radiobiology of Glioblastoma 139 153 .
HONGWEI LI, JUNNING ZHENG, RUIYUN GUAN, ZIFENG ZHU & XIANHOU YUAN. (2015) Tyrphostin AG 1296 induces glioblastoma cell apoptosis in vitro and in vivo. Oncology Letters 10:6, pages 3429-3433.
Crossref
Michael Seifert, Martin Garbe, Betty Friedrich, Michel Mittelbronn & Barbara Klink. (2015) Comparative transcriptomics reveals similarities and differences between astrocytoma grades. BMC Cancer 15:1.
Crossref
Enrica Fabbri, Eleonora Brognara, Giulia Montagner, Claudio Ghimenton, Albino Eccher, Cinzia Cantù, Susanna Khalil, Valentino Bezzerri, Lisa Provezza, Nicoletta Bianchi, Alessia Finotti, Monica Borgatti, Giuseppe Moretto, Marco Chilosi, Giulio Cabrini & Roberto Gambari. (2015) Regulation of IL-8 gene expression in gliomas by microRNA miR-93. BMC Cancer 15:1.
Crossref
Savita Jayaram, Manoj Kumar Gupta, Bhadravathi Marigowda Shivakumar, Madankumar Ghatge, Ankit Sharma, Rajani Kanth Vangala & Ravi Sirdeshmukh. (2015) Insights from Chromosome-Centric Mapping of Disease-Associated Genes: Chromosome 12 Perspective. Journal of Proteome Research 14:9, pages 3432-3440.
Crossref
Tatiana Randriarimanana, Alicia Chateau, Béatrice Faivre, Sophie Pinel & Cédric Boura. (2015) Sensitivity of glioma initiating cells to a monoclonal anti-EGFR antibody therapy under hypoxia. Life Sciences 137, pages 74-80.
Crossref
Yanming Chen, Zhongyong Wang, Xingliang Dai, Xifeng Fei, Yuntian Shen, Mingxia Zhang, Aidong Wang, Xiaonan Li, Zhimin Wang, Qiang Huang & Jun Dong. (2015) Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling. Cancer Letters 365:2, pages 174-181.
Crossref
Astrid Jeibmann, Kathrin Halama, Hanna Theresa Witte, Su Na Kim, Kristin Eikmeier, Björn Koos, Christian Klämbt & Werner Paulus. (2015) Involvement of CD9 and PDGFR in migration is evolutionarily conserved from Drosophila glia to human glioma. Journal of Neuro-Oncology 124:3, pages 373-383.
Crossref
Jiannan Zhang, Tao Chen, Qin Mao, Jinbo Lin, Jun Jia, Shanquan Li, Wenhao Xiong, Yingying Lin, Zhiqiang Liu, Xiaoyu Liu, Hailiang Zhao, Guisong Wang, Duo Zheng, Shuqi Qiu & Jianwei Ge. (2014) PDGFR‐β‐activated ACK 1‐ AKT Signaling Promotes Glioma Tumorigenesis . International Journal of Cancer 136:8, pages 1769-1780.
Crossref
Hongxiang Wang, Tao Xu, Ying Jiang, Hanchong Xu, Yong Yan, Da Fu & Juxiang Chen. (2015) The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas. Neoplasia 17:3, pages 239-255.
Crossref
Wen-Jie Chen, De-Shen He, Rui-Xue Tang, Fang-Hui Ren & Gang Chen. (2015) Ki-67 is a Valuable Prognostic Factor in Gliomas: Evidence from a Systematic Review and Meta-analysis. Asian Pacific Journal of Cancer Prevention 16:2, pages 411-420.
Crossref
América Carlo, Gisela Lira, Julieta Torreblanca & Óscar González. 2015. Endothelial Cell Plasticity in the Normal and Injured Central Nervous System. Endothelial Cell Plasticity in the Normal and Injured Central Nervous System 113 152 .
Hamid Bolouri. (2015) Network dynamics in the tumor microenvironment. Seminars in Cancer Biology 30, pages 52-59.
Crossref
Peter Man-Un Ung & Avner Schlessinger. (2014) DFGmodel: Predicting Protein Kinase Structures in Inactive States for Structure-Based Discovery of Type-II Inhibitors. ACS Chemical Biology 10:1, pages 269-278.
Crossref
Peter Yat Ming Woo, Ka Wing Michael See, Jason Kwan Ho Chow, Yung Chan, Hoi Tung Wong & Kwong Yau Chan. (2015) Hypertensive-Nimodipine Therapy for Middle Cerebral Artery Vasospasm after Resection of Glioblastoma Multiforme: A Case Report and Literature Review. Open Journal of Modern Neurosurgery 05:03, pages 76-83.
Crossref
Quoc-Nam Tran. (2015) Selection of genes using long-term influence and sensitivity analysis. Selection of genes using long-term influence and sensitivity analysis.
Merryl R. Lobo, Xiaoyan Wang, G. Yancey Gillespie, Randall L. Woltjer & Martin M. Pike. (2014) Combined Efficacy of Cediranib and Quinacrine in Glioma Is Enhanced by Hypoxia and Causally Linked to Autophagic Vacuole Accumulation. PLoS ONE 9:12, pages e114110.
Crossref
Sylvia Moeckel, Katharina Meyer, Petra Leukel, Fabian Heudorfer, Corinna Seliger, Christina Stangl, Ulrich Bogdahn, Martin Proescholdt, Alexander Brawanski, Arabel Vollmann-Zwerenz, Markus J. Riemenschneider, Anja-Katrin Bosserhoff, Rainer Spang & Peter Hau. (2014) Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro. PLoS ONE 9:9, pages e108632.
Crossref
Dimitry A. Chistiakov & Vladimir P. Chekhonin. (2014) Extracellular vesicles shed by glioma cells: pathogenic role and clinical value. Tumor Biology 35:9, pages 8425-8438.
Crossref
Sanne A.M. van Lith, Anna C. Navis, Kiek Verrijp, Simone P. Niclou, Rolf Bjerkvig, Pieter Wesseling, Bastiaan Tops, Remco Molenaar, Cornelis J.F. van Noorden & William P.J. Leenders. (2014) Glutamate as chemotactic fuel for diffuse glioma cells: Are they glutamate suckers?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:1, pages 66-74.
Crossref
Janna Paulsson, Monika Ehnman & Arne Östman. (2014) PDGF receptors in tumor biology: prognostic and predictive potential. Future Oncology 10:9, pages 1695-1708.
Crossref
Xue‑Bo Han, Hui‑Ping Zhang, Cheng‑Jian Cao, Yan‑Hua Wang, Jue Tian, Xiao‑Ling Yang, An‑Ning Yang, Jie Wang, Yi‑Deng Jiang & Hua Xu. (2014) Aberrant DNA methylation of the PDGF gene in homocysteine‑mediated VSMC proliferation and its underlying mechanism. Molecular Medicine Reports.
Crossref
Xiaoping Zhang, Hua Lv, Qingyu Zhou, Rana Elkholi, Jerry E. Chipuk, M.V. Ramana Reddy, E. Premkumar Reddy & James M. Gallo. (2014) Preclinical Pharmacological Evaluation of a Novel Multiple Kinase Inhibitor, ON123300, in Brain Tumor Models. Molecular Cancer Therapeutics 13:5, pages 1105-1116.
Crossref
Kriti Mittal, John Ebos & Brian Rini. (2014) Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond. Seminars in Oncology 41:2, pages 235-251.
Crossref
Julie Sesen, Anne Cammas, Sarah Scotland, Bertand Elefterion, Anthony Lemarié, Stefania Millevoi, Lijoy Mathew, Cathy Seva, Christine Toulas, Elizabeth Moyal & Nicolas Skuli. (2014) Int6/eIF3e Is Essential for Proliferation and Survival of Human Glioblastoma Cells. International Journal of Molecular Sciences 15:2, pages 2172-2190.
Crossref
Debmalya Barh, Angelo Carpi, Mukesh Verma & Mehmet GunduzYusuf Izci. 2014. Cancer Biomarkers. Cancer Biomarkers 199 218 .
Takuya Furuta, Mitsutoshi Nakada, Kouichi Misaki, Yasunori Sato, Yutaka Hayashi, Yasuni Nakanuma & Jun-ichiro Hamada. (2013) Molecular analysis of a recurrent glioblastoma treated with bevacizumab. Brain Tumor Pathology 31:1, pages 32-39.
Crossref
Kirsten Hattermann & Rolf Mentlein. 2014. Glioma Cell Biology. Glioma Cell Biology 153 185 .
Ricardo Cabezas, Daniel Torrente, Marco Fidel Avila, Jannet González & George Emilio Barreto. 2014. Advances in Computational Biology. Advances in Computational Biology 29 39 .
Anna C Navis, Simone P Niclou, Fred Fack, Daniel Stieber, Sanne van Lith, Kiek Verrijp, Alan Wright, Jonathan Stauber, Bastiaan Tops, Irene Otte-Holler, Ron A Wevers, Arno van Rooij, Stefan Pusch, Andreas von Deimling, Wikky Tigchelaar, Cornelis JF van Noorden, Pieter Wesseling & William PJ Leenders. (2013) Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG. Acta Neuropathologica Communications 1:1.
Crossref
Elizabeth M Jennings, Jeffrey S Morris, Raymond J Carroll, Ganiraju C Manyam & Veerabhadran Baladandayuthapani. (2013) Bayesian methods for expression-based integration of various types of genomics data. EURASIP Journal on Bioinformatics and Systems Biology 2013:1.
Crossref
Hazel A. Rogers, Cerys Mayne, Rebecca J. Chapman, John-Paul Kilday, Beth Coyle & Richard G. Grundy. (2013) PI3K Pathway Activation Provides a Novel Therapeutic Target for Pediatric Ependymoma and Is an Independent Marker of Progression-Free Survival. Clinical Cancer Research 19:23, pages 6450-6460.
Crossref
Peng Cheng. (2013) Platelet-derived growth factor BB mediates the glioma-induced migration of bone marrow-derived mesenchymal stem cells by promoting the expression of vascular cell adhesion molecule-1 through the PI3K, P38 MAPK and NF-κB pathways. Oncology Reports.
Crossref
Yanyang Tu, Xingchun Gao, Gang Li, Hualin Fu, Daxiang Cui, Hui Liu, Weilin Jin & Yongsheng Zhang. (2013) MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation, and Cancer Stem-like Cell Self-Renewal by Targeting the Polycomb Group Gene Bmi1 . Cancer Research 73:19, pages 6046-6055.
Crossref
Maria Linda Cruceru, Monica Neagu, Jean‐Baptiste Demoulin & Stefan N. Constantinescu. (2013) Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms. Journal of Cellular and Molecular Medicine 17:10, pages 1218-1235.
Crossref
Danielle Kamato, Micah L. Burch, Terrence J. Piva, Hossein Babaahmadi Rezaei, Muhamad Ashraf Rostam, Suowen Xu, Wenhua Zheng, Peter J. Little & Narin Osman. (2013) Transforming growth factor-β signalling: Role and consequences of Smad linker region phosphorylation. Cellular Signalling 25:10, pages 2017-2024.
Crossref
Miriam Sciaccaluga, Giuseppina D’Alessandro, Francesca Pagani, Giuseppina Ferrara, Nadia Lopez, Tracy Warr, Paolo Gorello, Alessandra Porzia, Fabrizio Mainiero, Antonio Santoro, Vincenzo Esposito, Giampaolo Cantore, Emilia Castigli & Cristina Limatola. (2013) Functional Cross Talk between CXCR4 and PDGFR on Glioblastoma Cells Is Essential for Migration. PLoS ONE 8:9, pages e73426.
Crossref
Martin H. M. Sailer, Alexandra Gerber, Cristóbal Tostado, Gregor Hutter, Dominik Cordier, Luigi Mariani & Marie-Françoise Ritz. (2013) Non-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signaling . Journal of Cell Science 126:16, pages 3533-3540.
Crossref
J. Xiong, L. Zhou, M. Yang, Y. Lim, Y.-h. Zhu, D.-l. Fu, Z.-w. Li, J.-h. Zhong, Z.-c. Xiao & X.-F. Zhou. (2013) ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro. Neuro-Oncology 15:8, pages 990-1007.
Crossref
Chunsik Lee, Fan Zhang, Zhongshu Tang, Yizhi Liu & Xuri Li. (2013) PDGF-C: a new performer in the neurovascular interplay. Trends in Molecular Medicine 19:8, pages 474-486.
Crossref
David Akhavan, Alexandra L. Pourzia, Alex A. Nourian, Kevin J. Williams, David Nathanson, Ivan Babic, Genaro R. Villa, Kazuhiro Tanaka, Ali Nael, Huijun Yang, Julie Dang, Harry V. Vinters, William H. Yong, Mitchell Flagg, Fuyuhiko Tamanoi, Takashi Sasayama, C. David James, Harley I. Kornblum, Tim F. Cloughesy, Webster K. Cavenee, Steven J. Bensinger & Paul S. Mischel. (2013) De-Repression of PDGFRβ Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients . Cancer Discovery 3:5, pages 534-547.
Crossref